PLK1 and breast cancer: Consequently, a valuable prognostic effect of PLK1 for poorer OS was found in four studies with a total of 601 BC patients (HR = 3.438, 95% CIs: 2.293-5.154, P < 0.001, I2 = 0%, P = 0.487).